Abstract

To analyze the financial burden associated with the management of chronic myeloid leukemia (CML) patients who failed treatment with two or more tyrosine kinase inhibitors (TKI) through the Brazilian private market’s perspective.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Increased Risk of Cardiovascular Events Associated with TKI Treatment in Chronic Phase Chronic Myeloid Leukemia. Data from Swedish Population-Based Registries
Torsten Dahlén ... Leif Stenke
Blood | VOL. 124
Torsten Dahlén, et. al.Torsten Dahlén ... Leif Stenke
06 Dec 2014
Presence of novel compound BCR-ABL mutations in late chronic and advanced phase imatinib sensitive CML patients indicates their possible role in CML progression
Afia Muhammad Akram ... Mudassar Iqbal
Cancer Biology & Therapy | VOL. 18
Afia Muhammad Akram, et. al.Afia Muhammad Akram ... Mudassar Iqbal
21 Feb 2017
High-Throughput DNA Sequencing Identifies a Novel Splice-Site Mutation in Fanconi Anemia Pathway Gene FANCD2 As a Potential Biomarker of Early and Late Phases of Disease Progression in Chronic Myeloid Leukemia
Nawaf Alanazi ... Zafar Iqbal
Blood | VOL. 140
Nawaf Alanazi, et. al.Nawaf Alanazi ... Zafar Iqbal
15 Nov 2022
Accumulation of DNA Damage and Alteration of the DNA Damage Response in Chronic Myeloid Leukemia
Henning D Popp ... Alice Fabarius
Blood | VOL. 134
Henning D Popp, et. al.Henning D Popp ... Alice Fabarius
13 Nov 2019
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
Generating utilities for the CS-Base: a novel, generic, and patient-centered health-outcome measure
Xin Zhang ... Paul Fm Krabbe
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Xin Zhang, et. al.Xin Zhang ... Paul Fm Krabbe
06 Jul 2024
Do Behavioral Characteristics Influence the Breast Cancer Diagnosis Delay? Evidence From French Retrospective Data
Christine Le Clainche ... Jean-Christophe Vergnaud
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Christine Le Clainche, et. al.Christine Le Clainche ... Jean-Christophe Vergnaud
06 Jul 2024
Key Issues of Economic Evaluations for Health Technology Assessment in China: A Nationwide Expert Survey
Gordon G Liu ... Huajie Jin
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Gordon G Liu, et. al.Gordon G Liu ... Huajie Jin
06 Jul 2024
Valuation of Multi-Dimensional Health States With a Bolt-On: Is There a Shortcut?
Zhihao Yang ... Nan Luo
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Zhihao Yang, et. al.Zhihao Yang ... Nan Luo
06 Jul 2024
View more papers